ExpreS2ion Biotech Valuation
| EXPRS2 Stock | SEK 25.40 0.45 1.80% |
At this time, the firm appears to be overvalued. ExpreS2ion Biotech shows a prevailing Real Value of kr20.09 per share. The current price of the firm is kr25.4. Our model computes the value of ExpreS2ion Biotech from reviewing the firm fundamentals such as Operating Margin of (20.75) %, shares outstanding of 37.15 M, and Shares Owned By Institutions of 1.75 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ExpreS2ion Biotech's price fluctuation is somewhat reliable at this time. Calculation of the real value of ExpreS2ion Biotech is based on 3 months time horizon. Increasing ExpreS2ion Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ExpreS2ion Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ExpreS2ion Stock. However, ExpreS2ion Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.4 | Real 20.09 | Hype 25.4 | Naive 21.91 |
The real value of ExpreS2ion Stock, also known as its intrinsic value, is the underlying worth of ExpreS2ion Biotech Company, which is reflected in its stock price. It is based on ExpreS2ion Biotech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ExpreS2ion Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ExpreS2ion Biotech Holding helps investors to forecast how ExpreS2ion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ExpreS2ion Biotech more accurately as focusing exclusively on ExpreS2ion Biotech's fundamentals will not take into account other important factors: ExpreS2ion Biotech Total Value Analysis
ExpreS2ion Biotech Holding is currently projected to have takeover price of 361.15 M with market capitalization of 487.85 M, debt of 3.48 M, and cash on hands of 10.14 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ExpreS2ion Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
361.15 M | 487.85 M | 3.48 M | 10.14 M |
ExpreS2ion Biotech Investor Information
The book value of the company was currently reported as 2.75. The company recorded a loss per share of 1.55. ExpreS2ion Biotech had not issued any dividends in recent years. The entity had 40:1 split on the 30th of October 2024. ExpreS2ion Biotech Holding is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.ExpreS2ion Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ExpreS2ion Biotech has an asset utilization ratio of 8.05 percent. This suggests that the Company is making kr0.0805 for each dollar of assets. An increasing asset utilization means that ExpreS2ion Biotech Holding is more efficient with each dollar of assets it utilizes for everyday operations.ExpreS2ion Biotech Ownership Allocation
ExpreS2ion Biotech holds a total of 37.15 Million outstanding shares. Roughly 98.25 percent of ExpreS2ion Biotech outstanding shares are held by general public with 1.75 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.ExpreS2ion Biotech Profitability Analysis
The company reported the revenue of 12.23 M. Net Loss for the year was (43.92 M) with profit before overhead, payroll, taxes, and interest of 1.07 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ExpreS2ion Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ExpreS2ion Biotech and how it compares across the competition.
About ExpreS2ion Biotech Valuation
The stock valuation mechanism determines ExpreS2ion Biotech's current worth on a weekly basis. Our valuation model uses a comparative analysis of ExpreS2ion Biotech. We calculate exposure to ExpreS2ion Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ExpreS2ion Biotech's related companies.ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. ExpreS2ion Biotech operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 15 people.
8 Steps to conduct ExpreS2ion Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ExpreS2ion Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ExpreS2ion Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ExpreS2ion Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ExpreS2ion Biotech's revenue streams: Identify ExpreS2ion Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ExpreS2ion Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ExpreS2ion Biotech's growth potential: Evaluate ExpreS2ion Biotech's management, business model, and growth potential.
- Determine ExpreS2ion Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ExpreS2ion Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ExpreS2ion Stock analysis
When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world |